2011Zhongguo yiyuan ganranxue zazhiRequires access

Study on peripheral blood T lymphocyte subsets of patients with lung cancer and lung infection

Qiong Tang

Open publisher page 0 citations

Abstract

OBJECTIVE To study the variation of peripheral blood T lymphocyte subsets of patients with lung cancer and lung infection.METHODS A total of 93 patients with lung cancer in our hospital from Jan 2008 to Dec 2010 were selected as research object,and they were divided into control group(without infection group)47 cases and observation group(with infection group)46 cases,then the CD3+,CD4+,CD8+,CD4+/CD8+ and NK of two groups were analyzed and compared.RESULTS The CD3+,CD4+,CD4+/CD8+ and NK of observation group [(60.82±5.96)%,(30.58±3.78)%,1.02±0.15,(19.20±5.97)%] were lower than those of control group [(65.38±5.89)%,(37.85±3.69)%,1.43±0.18,(22.76±6.12)%].CD8+ was higher than that of control group [(25.76±2.58)% vs(29.75±2.66)%],(P0.05).And CD3+,CD4+,CD8+,CD4+/CD8+ and NK of different stages all showed this regulation.CONCLUSION The patients with lung cancer and lung infection are more immunocompromised,and it should pay attention to the course of treatment.

About this research paper

What this paper is about

OBJECTIVE To study the variation of peripheral blood T lymphocyte subsets of patients with lung cancer and lung infection.METHODS A total of 93 patients with lung cancer in our hospital from Jan 2008 to Dec 2010 were selected as research object,and they were divided into control group(without infection group)47 cases and observation group(with infection group)46 cases,then the CD3+,CD4+,CD8+,CD4+/CD8+ and NK of two groups were analyzed and compared.RESULTS The CD3+,CD4+,CD4+/CD8+ and NK of observation group [(60.82±5.96)%,(30.58±3.78)%,1.02±0.15,(19.20±5.97)%] were lower than those of control group [(65.38±5.89)%,(37.85±3.69)%,1.43±0.18,(22.76±6.12)%].CD8+ was higher than that of control group [(25.76±2.58)% vs(29.75±2.66)%],(P0.05).And CD3+,CD4+,CD8+,CD4+/CD8+ and NK of different stages all showed this regulation.CONCLUSION The patients with lung cancer and lung infection are more immunocompromised,and it should pay attention to the course of treatment.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To study the variation of peripheral blood T lymphocyte subsets of patients with lung cancer and lung infection.METHODS A total of 93 patients with lung cancer in our hospital from Jan 2008 to Dec 2010 were selected as research object,and they were divided into control group(without infection group)47 cases and observation group(with infection group)46 cases,then the CD3+,CD4+,CD8+,CD4+/CD8+ and NK of two groups were analyzed and compared.RESULTS The CD3+,CD4+,CD4+/CD8+ and NK of observation group [(60.82±5.96)%,(30.58±3.78)%,1.02±0.15,(19.20±5.97)%] were lower than those of control group [(65.38±5.89)%,(37.85±3.69)%,1.43±0.18,(22.76±6.12)%].CD8+ was higher than that of control group [(25.76±2.58)% vs(29.75±2.66)%],(P0.05).And CD3+,CD4+,CD8+,CD4+/CD8+ and NK of different stages all showed this regulation.CONCLUSION The patients with lung cancer and lung infection are more immunocompromised,and it should pay attention to the course of treatment.

Key concepts: Lung cancer, CD8, Lung, Peripheral blood, CD3, Medicine, Internal medicine, Gastroenterology

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on peripheral blood T lymphocyte subsets of patients with lung cancer and lung infection — Research Paper | ScholarLens